STAT-NAT®COVID-19 MULTI is the new configuration of ready-to-use lyo Real-Time PCR mix for the detection of novel coronavirus disease. The world is experiencing a fast increase of SARS-CoV-2 testing demand and needs a more rapid and simplified testing capacity. STAT-NAT®COVID 19 MULTI is the answer for these new needs. The all in one tube approach […]READ MORE "STAT-NAT®COVID-19 MULTI, the value of simplicity"
STAT-NAT® RNA Mix is the universal platform for nucleic acids amplification techniques (RT-PCR, Real Time RT-PCR) on RNA samples extracted from any biological material. It is a universal RNA Master Mix, that can be used for the extraction and the amplification of viral RNA from human samples. The kit is made with Sentinel’s STAT-NAT® patented […]READ MORE "Another weapon against COVID-19"
Based on the 2019 ESC/EAS Guidelines for the management of dyslipidaemias, the new consensus-based recommendations from EAS and EFLM are now available. The 2019 ESC/EAS Guidelines recommend the Lp(a) analysis for the population over 40-years-old, in order to identify individuals with a high risk to develop atherosclerotic cardiovascular disease. Clinicians claim that a one-off measurement […]READ MORE "The new consensus-based recommendations from EAS and EFLM are now available."
The International Federation of Clinical Chemistry and Laboratory Medicine IFCC has established a Task Force on COVID-19, in order to face the Public Health Emergency. Our CTO NAT Maurizio Gramegna has been selected by IFCC to be one of the Corporate Members of the Task Force on COVID-19, thanks to his long-lasting experience in […]READ MORE "Our CTO NAT Maurizio Gramegna is one of the Corporate Members of the IFCC Task Force on COVID-19"
As every year, the Dutch RIVM publishes the report “Monitoring and Evaluation of the Colorectal Cancer Screening Programme”, regarding the CRC Screening Program in the Netherlands, with which the Institute proudly underlines the successful results obtained. This outcome, regards all aspects of the procedure, from the enrollment of citizens, to the intake of samples, to […]READ MORE "Our FOB Gold® system is the perfect partner for an efficient screening program"
Proud to be part of the Companies that don’t give up in front of a challenge! Also this year, Sentinel is one of the 1000 Champions of the Made In Italy. We will keep doing our best for our Country and we will continue to produce innovative IVDs, in order to support the clinical diagnoses […]READ MORE "We are an Italian Champion"
Our ready-to-use lyo Real-Time PCR mix for the detection of novel coronavirus disease is ready. We have developed two kits: COVID-19 HK, that follows the Hong Kong protocol and COVID-19 B, based on Berlin protocol. These two kits will assure you the highest sensitivity and specificity. More info available here!READ MORE "Our ready-to-use Real-Time PCR mix for the detection of novel coronavirus disease is ready"
From February 3rd to 6th we will be in Dubai at MEDLAB Middle East. Have you already booked your flight? We are at booth Z4.G11 in Hall 4. See you there!READ MORE "Meet us at MEDLAB DUBAI"
Ann Arbor, MI USA and Milan, Italy (December 9, 2019) – NeuMoDx™ Molecular, a sample-to-result molecular diagnostic company focused on developing testing solutions for hospital and commercial reference laboratory customers, and Sentinel Diagnostics, a leading company engaged in the development and production of diagnostic kits for Clinical Chemistry, Immunochemistry and Molecular Biology, announced today their […]READ MORE "NeuMoDx™ Molecular and Sentinel Diagnostics form a partnership to develop multiple new assays for the NeuMoDx™ 96 and 288 Molecular Systems."
We would like to invite you to join us at MEDICA, Düsseldorf, from November 18th to the 21st. We will be very happy to welcome you at booth #D12-1 in Hall 3. Contact us now to arrange a meeting and learn more about our products and services (click here). See you there!READ MORE "Meet us at MEDICA 2019"